CUBERES-ALTISENT, Mar a Rosa,SOL - CARANDELL, Lluis,GARC A - COUCEIRO, Urko
申请号:
LT10782303
公开号:
LT2503993T
申请日:
2010.11.25
申请国别(地区):
LT
年份:
2016
代理人:
摘要:
The present invention relates to 4-[-2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine salts, specifically to the hydrochloride, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.